Harness Therapeutics awarded grant from Michael J. Fox Foundation
The grant funds a two-year proof-of-concept study targeting GCase and LIMP2 upregulation via MISBA platform.
Latest Pharmaceuticals News
Stay informed with the latest news and media coverage for the biggest companies in Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
Latest news in Pharmaceuticals
Company announcements
AlzeCure Pharma announces positive Phase Ib results for NeuroRestore ACD856
The study met its safety and tolerability endpoints, with increased drug concentration in blood and cerebrospinal fluid, supporting dose selection for Phase II.
Vivesto reports positive results from Cantrixil PK/toxicology study
The study shows Cantrixil was well tolerated intravenously in dogs, supporting development toward Phase I in AML.
AlzeCure Pharma's rights issue subscription period begins today
The offering aims to raise approximately SEK 30.1 million and is fully secured by major shareholders.
Unlock all announcements with a free trial
Media coverage
AlzeCure Pharma: Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer's
STOCKHOLM, SE / ACCESS Newswire / June 16, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting...
Novartis: Are Imitators Endangering an Important Business Segment?
Novartis has built a large business with radioligand therapies. Now the world's first copy of such a drug is in the starting blocks. What are the consequences?
Norges Bank supports Grifols at its board meeting and CalPERS rejects salaries and re-election of directors
Grifols will hold its shareholders' meeting on June 18. The Catalan company faces the meeting with the support of Norges Bank, although not without discrepancies...
Bristol Myers Squibb’s phase 3CheckMate -274 trial of Opdivo in patients with high-risk, muscle-invasive urothelial carcinoma meets primary endpoionts
Bristol Myers Squibb’s phase 3CheckMate -274 trial of Opdivo in patients with high-risk, muscle-invasive urothelial carcinoma meets primary endpoionts: Princeton, New Jersey Sat ...
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily or weekly news updates delivered straight to your inbox
Start for freePharmaceuticals companies
Browse the top companies in Pharmaceuticals and stay on top of their latest developments.
A
- AB Science
- Abarceo Pharma
- Abbott
- AbbVie
- Abcuro
- Abliva
- Acelot
- Active Biotech
- Advanz Pharma
- Agarose Bead Technologies
- Agomab Therapeutics (Agomab)
- Akero Therapeutics (Akero)
- AL-S Pharma
- Alcolase
- Allarity Therapeutics (Allarity)
- Alligator Bioscience
- Alsonex
- Altos Labs (Altos)
- AlzeCure Pharma
- Alzinova
- Amgen
- Amylyx Pharmaceuticals (Amylyx)
- Annexin Pharmaceuticals
- Annexon Biosciences
- Aperture Therapeutics
- Aquilus Pharmaceuticals
- argenx
- Asarina Pharma
- Ascelia Pharma
- AstraZeneca
- Aura Biosciences
- Axoltis
B
C
- Camurus
- Can-Fite BioPharma (Can-Fite)
- Candel Therapeutics
- Canurta Therapeutics
- Cardinal Health
- Cellcolabs
- Celosia Therapeutics
- Cencora
- Charles River Laboratories (Charles River)
- Chemomab Therapeutics (Chemomab)
- Cinclus Pharma
- Clene Inc. (Clene)
- Compugen
- Contract Pharma Solutions
- Coya Therapeutics
- Cresco Labs
- CRISPR Therapeutics
- CTS Ltd (CTS)
D
E
H
I
L
M
N
O
P
R
S
- Saniona
- Sanity Group
- Sanofi
- Sartorius
- Schrödinger
- Sedana Medical (Sedana)
- SELLAS Life Sciences (SELLAS)
- Sigrid Therapeutics
- Sironax
- Sobi
- Sobrera Pharma (Sobrera)
- Soligenix
- Spago Nanomedical
- SpectraCure
- Spinogenix
- Sprint Bioscience
- Stayble Therapeutics (Stayble)
- Stenocare
- Structure Therapeutics (Structure)
- Surrozen
- Syndax